Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
5.00
-1.48%
After-hours: Aug 15, 2025, 07:53 PM EDT
Evoke Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.31M | -1.19M | -1.31M | -1.27M | -1.58M | -1.99M | -1.69M | -1.87M | -2.24M | -1.8M | -2.01M | -2.23M | -2.17M | -1.67M | -1.97M | -2.29M | -2.61M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 84.38K | 260.93K | 131.59K | 126.58K | 254.03K | 281.64K | 281.76K | 280.14K | 284.57K | 354.97K | 355.75K | 366.92K | 381.06K | 454.2K | 464K | 399.41K | 561.35K |
Other Working Capital | n/a | -451.08K | 1.34M | 459.83K | -836.08K | 25.92K | 216.74K | 212.68K | 100.78K | -942.59K | 188.33K | 559.48K | 243.27K | -714.16K | 189.31K | 183.64K | -455.81K |
Other Non-Cash Items | n/a | 142.71K | 126.03K | 515.7K | 920.86K | 13.37K | 39.47K | 38.56K | 37.68K | 24.6K | 221.06K | 433.65K | 446.76K | 30K | 518.06K | -962 | -104.17K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -450.92K | 236.08K | 195.37K | -1.38M | 586.29K | 331.07K | 342.85K | 289.93K | -1.08M | 544.76K | 492.75K | 177.57K | -809.04K | -4.39M | 381.7K | -804.8K |
Operating Cash Flow | -997.51K | -1.24M | -818.7K | -820.62K | -2.58M | -1.11M | -1.04M | -1.21M | -1.63M | -2.51M | -1.1M | -1.37M | -1.62M | -2M | -5.89M | -1.51M | -2.95M |
Capital Expenditures | n/a | n/a | 5.00 | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -3.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 3.5M | 2.98M | 295.7K | 824.51K | -119.3K | n/a | n/a | n/a | -148.99K | 148.99K | -148.99K | n/a | 313.11K | n/a | -1.26M | n/a |
Financial Cash Flow | 25K | 3.5M | 2.98M | 295.7K | 7.54M | -119.3K | n/a | n/a | n/a | 7.29K | n/a | 7.12M | 171.52K | n/a | 313.11K | 45.45K | 13.07M |
Net Cash Flow | -972.51K | 2.26M | 2.16M | -524.92K | 4.96M | -1.23M | -1.04M | -1.21M | -1.63M | -2.51M | -1.1M | 5.75M | -1.44M | -2M | -5.58M | -1.47M | 10.12M |
Free Cash Flow | -997.51K | -1.24M | -818.69K | -820.62K | -2.58M | -1.11M | -1.04M | -1.21M | -1.63M | -2.51M | -1.1M | -1.37M | -1.62M | -2M | -5.89M | -1.51M | -2.95M |